CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-26 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,609 | $0.52 | $1K | 683,521 |
| 2023-07-25 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −234 | $0.50 | $117 | 52,867 |
| 2023-07-25 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,390 | $0.50 | $695 | 187,696 |
| 2023-07-25 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,803 | $0.50 | $1K | 686,130 |
| 2023-07-24 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,438 | $0.54 | $777 | 189,086 |
| 2023-07-24 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,887 | $0.54 | $2K | 688,933 |
| 2023-07-24 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −234 | $0.56 | $131 | 53,101 |
| 2023-07-21 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,333 | $0.61 | $813 | 190,524 |
| 2023-07-21 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,663 | $0.61 | $2K | 691,820 |
| 2023-07-21 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −223 | $0.61 | $136 | 53,335 |
| 2023-07-20 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,361 | $0.64 | $871 | 191,857 |
| 2023-07-20 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,710 | $0.64 | $2K | 694,483 |
| 2023-07-20 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −229 | $0.64 | $147 | 53,558 |
| 2023-07-19 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,335 | $0.65 | $868 | 193,218 |
| 2023-07-19 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,646 | $0.65 | $2K | 697,193 |
| 2023-07-19 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −228 | $0.63 | $144 | 53,787 |
| 2023-07-18 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −249 | $0.56 | $139 | 54,015 |
| 2023-07-18 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,968 | $0.56 | $2K | 699,839 |
| 2023-07-18 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,484 | $0.56 | $831 | 194,553 |
| 2023-07-17 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −244 | $0.65 | $159 | 54,264 |
Page 12 of 23 · 441 trades